Lakeland Industries, Inc. (LAKE) Earnings Call Transcript & Summary
December 10, 2020
Earnings Call Speaker Segments
Charlie Roberson
executiveThanks, and good afternoon, everyone. We’re grateful that you’ve made time to be with us on this call covering our financial results for fiscal 2021’s third quarter. With me today is Allen Dillard, Lakeland’s Chief Financial Officer. Our third quarter was outstanding, and I think we delivered an unmistakable signal to the worldwide PPE market—and, we hope, to shareholders and investors too—that Lakeland is the place to turn for protective apparel, not just when black swan events occur, but at any point in any year when quality and delivery matter most. Our manufacturing capacity, resilience, and adaptability have no equal, and our lines are growing so we can build lasting momentum with customers across the globe, driving profitability improvements that can be sustained when no black swan event like COVID-19 is present. Any review of how we performed in the third quarter would be incomplete without acknowledging how far our worldwide team has gone to help the health care community defend against COVID-19. Even as we took steps to protect the safety and well-being of our employees and their families, along with our partners and customers everywhere, we are lucky to have a team that has met the challenge again and again. During COVID-19, we did a good job meeting and going beyond what Lakeland is supposed to do as a global PPE supplier—that's personal protective equipment. That helped reduce shortages of PPE and kept health care workers and first responders around the world safe. Because our employees are dedicated, because we can scale up production, and because we've become more efficient, we are—whether that's a sad thing or a good thing, depending on your view—one of the big corporate winners from the pandemic. Today we're reporting financial results, and those might get a lot of attention, but we realize there's something more important in the news: the FDA is looking at the COVID-19 vaccine candidates from Pfizer/BioNTech and from Moderna. Those are 2 of the vaccines the world is considering for use. No matter which vaccines are deployed, and regardless of when or where they are given, we expect PPE requirements to stay in place. Initial patient injection with the vaccines will take roughly 6 months. During that entire period, protective apparel will be needed by those administering the vaccine, and it will continue to be used in caring for those infected plus all related cleanup and remediation work. Assuming the COVID-19 situation is mostly resolved—though perhaps not entirely—by the middle of 2021, Lakeland should emerge from this period with both sales growth and durable performance strengths. First, we'll have gained numerous new customers in the industrial sector. Second, our brand will be stronger worldwide as a maker of personal protective equipment capable of supplying high-quality garments in large volumes during industry shortages in a way no competitor can match. Third, we'll hold an advantageous standing as arguably the most globally positioned PPE producer that actually owns its own manufacturing operations, which distinguishes us from the biggest companies in this market. Fourth, we'll have new products carrying higher margins, targeting substantial market segments that previously experienced unreliable supply before our offerings became available. Item five: the product categories we already sell apart from disposables and chemical suits—things like wovens, FR garments, high visibility items and other apparel—should experience renewed demand as customers shift their spending away from COVID-19 toward conventional industrial outlays. Item six: what the pandemic taught us about getting the most from our spending on technology, manufacturing and product planning. That covers our gross margin approach, among other things. The way the industry has evolved has given PPE a human face. It won't remain a back-office purchasing matter anymore; it has turned into a mainstream, frontline essential that is creating—that is opening up a fresh market possibility through institutional cleaning; and item seven: a cash reserve that stood above $4 million as of October 31, 2020, and keeps expanding. Lakeland's third quarter of fiscal 2021 built on the record results posted earlier in the year; we showed we can adjust our worldwide production capability to meet soaring PPE needs across the globe at pivotal moments. Lakeland's brand equity continues to build, since our reputation for reliable supply and quality keeps climbing — something shown by the unprecedented number of direct container shipment orders that came in during Q3 from both first-time customers and those we've served for years. After setting a fresh standard of excellence for PPE manufacturers worldwide when our second quarter wrapped up, we raised that standard yet again over the course of Q3. Because of durable improvements along with sustained COVID-19-related demand, our performance delivered records for any third quarter in revenue, gross profit and margin, operating income, and free cash flow. When you look at how this quarter stacks up against every other one in our company's past, we set new highs across the board: gross margin as a percentage of sales, operating income and operating margin, EBITDA and EBITDA margin, plus free cash flow. What matters even more is that as we exit the COVID-19 era, we anticipate having picked up essential share of the market, owning a brand associated with dependability, and gaining a sharper view of lasting improvements that ought to push our business performance far past where it stood prior to the outbreak. The third quarter brought a rebound in economic activity around the globe, which let our traditional industrial businesses grow compared with the second quarter, even though baseline revenues remained below where they were before the pandemic. According to The Conference Board, the U.S. The economy on its own—which historically has made up about half of what we report as consolidated revenue, it's worth pointing out—contracted 5% during the first quarter of calendar 2020, then 31.4% in that year's second quarter. A 33.1% bounce-back arrived in the third quarter; and according to Bureau of Economic Analysis, or BEA, data, in calendar 2020's third quarter the U.S. economy was 3.5% smaller than it had been in calendar 2019's fourth quarter. Within our own third quarter, the traditional core business—industrial markets being the main part—fell an estimated 19% globally compared with the prior-year period. Still, we anticipate continued improvement from the bottom we hit in our fiscal second quarter, thanks to COVID-19-related sales fading and industrial activity continuing to strengthen. Despite that sequential gain, our core industrial segment's expansion continues to be outpaced by PPE-related COVID-19 demand. We recorded increased need for COVID-19-linked products for a fourth straight quarter. About 35% of sales in our fiscal 2021 third quarter came from COVID-19 demand. As evidence of our worldwide diversification, international revenue increased at a quicker pace than what we achieved domestically. Compared with our second quarter, international sales were up 19% sequentially in the third quarter, and they climbed 84% versus the same period a year earlier. Even though overall U.S. Sales came in 20% higher than they did during the third quarter of the previous fiscal year, and we attribute that uneven expansion to stronger prospects and traction in growing our penetration of markets overseas—something that will keep spreading our revenue across more regions down the road. Interest in single-use and chemical-protective apparel remains strong. You can see it in how many first-time buyers we brought on over the last 9 months, plus the big jump in orders sized by the container during our third quarter, since we got goods out the door while plenty of competitors simply couldn't.
Charlie Roberson
executiveTwo important new product categories—one for critical environments and one for high-performance wear—made fairly meaningful advances; that matters because they fit into our longer-range plan for ongoing top-line expansion and gross margins that stay higher over time. On the manufacturing side, output from producers in major markets such as the U.S. has been moving closer to matching demand; we have managed the demand pattern well, securing sales and adjusting our production to fit. Around the world, prices and incoming orders tied to COVID-19 demand should stay above where they sat before the pandemic, though they are projected to ease between now and the middle of 2021. While that shift plays out, pricing leverage has worked in our favor. Additional items that shaped our third quarter performance include more direct container shipments, greater consolidated volume, ongoing gains in manufacturing efficiency and the way we manage our product mix. Together these elements produced our robust gross profit showing, and we will keep overseeing these levers to push margins past where they stood before the pandemic. To illustrate, we expect our disposable and chemical SKUs to rise by roughly 50% relative to COVID response levels as we transition into our post-COVID sustainable product mix approach. That will bring about a lasting cut in SKUs of roughly 40%, generating the anticipated gains in inventory efficiency and, in the end, profitability. Over the last 4 quarters we have picked up a great deal, and we think that will support durable growth in revenue as well as profitability. Rationalizing SKUs is essential to our sustained — to sustaining elevated financial results in a post-COVID-19 operating setting. Trimming underperforming SKUs and introducing new higher-margin product lines for critical environment and high-performance wear are a couple of illustrations of what we are doing. These higher-value advanced product lines stand apart within the industry, so we anticipate reduced global competition relative to lower-priced traditional disposable garments. The markets these two product lines target are mostly unaffected by economic swings and do not depend on COVID-19 response, and so they will act as a strong base for extending our core business product offering far into the future. Another element feeding our forward revenue growth plan is a new era of institutional cleaning along with wider acceptance of PPE, which has started to take shape and could open up a sizable lasting market opportunity. Requests to stockpile disposable and chemical apparel from government bodies in the U.S., Europe and other developing nations have already become publicly known. Since we control our own manufacturing and keep putting money into facilities, technology, processes and people, we have made considerable headway and are positioned to gain further from these supportive market dynamics. Beyond simply record financial results across the past 2 quarters, our numbers show a quality of earnings and cash flow that has gained from better profitability metrics, efficiencies on the factory floor and in distribution, and operating leverage. As we noted last quarter, COVID-19 gave us a proving ground for change that will serve Lakeland well far into the future. The leverage that is sustainable and the scalability in our business—both of which we demonstrated clearly during the third quarter—can be applied not just to black swan events in the future, but since so many of our improvements have staying power, we will use them to drive better performance going forward; with more than $40 million in cash at the close of the third quarter, we are ready for continued growth on a traditional basis and for any emergency situations that may come up. That brings my remarks to a close. I will now hand the call over to Allen, who will give a more thorough review of the company's financial results.
Allen Dillard
executiveAppreciate that, Charlie. Net sales for Q3 of fiscal 2021 totaled $41.5 million. Compared with the $35 million we posted in Q2 of this year, that's a gain of over 18%, and it's 51% above the $27.5 million recorded during the same quarter last year. On top of that, it's the sixth straight quarter in which our revenues have exceeded $27 million. Over the past 3 quarters, we've generated revenues north of $35 million. Turning to Q3 fiscal 2021 on a consolidated basis, U.S. sales were $17 million, accounting for 41% of total revenues, whereas international sales totaled $24.5 million, representing 59% of total revenues. That's measured against U.S. In the third quarter of fiscal 2020, we recorded $14.2 million in sales domestically, which accounted for 52% of the total, while our international business brought in $13.3 million, representing 48% of the total. The way our sales are spread across different regions looks a lot like what we experienced in the second quarter of this year. Compared to the same period a year ago, third quarter sales climbed considerably, reflecting how well-balanced our business is and the advantages we get from having a diversified geographic footprint. Looking at the third quarter on a year-over-year basis, our key international operations performed as follows: the U.K. came in at $5.6 million this year, compared with $2.4 million last year. Mexico saw sales increase by more than twofold, reaching $1.9 million, up from $0.9 million. In Asia, sales grew 39%, hitting $6.4 million, compared with $4.6 million. Canadian revenue climbed more than 60%, reaching $4.2 million, compared with $2.6 million during the same period a year earlier. In Latin America, we saw an increase of almost 90%, coming in at $3.6 million versus $1.9 million. Meanwhile, our other foreign markets posted a 120% gain, hitting $2.7 million, up from $900,000 twelve months prior. Looking at the third quarter relative to this fiscal year's second quarter, COVID-19-related sales pushed results higher across the U.S. and every international region aside from China. As I noted earlier, purchases for conventional industrial applications from our core customer base rose compared with the second quarter, a period when factory closures brought on by the pandemic had suppressed demand. Our non-COVID business also got a lift from fresh product lines and from picking up new accounts in disposables and chemicals, as buyers who couldn't source those items from any other maker worldwide turned to us. Turning now to how our product mix is diversifying: disposables remain our biggest category, climbing to $25.8 million, up from $23.8 million in this year's second quarter and $12.5 million in last year's third quarter. Chemical suits came in at $9.7 million, versus $6.2 million in this year's second quarter and $5.7 million in last year's third quarter. Organic growth helped both categories, though COVID-19 demand was the main factor. Turning to our product lines: fire-related offerings brought in $1.6 million during this year's third quarter, down from $1.7 million in this year's second quarter and from $2.8 million in last year's third quarter. Gloves contributed $0.5 million in the third quarter of fiscal '21 — unchanged from this year's second quarter, yet below the $0.7 million posted in the third quarter of fiscal 2020. High-visibility products reached $1.4 million, exceeding the $1 million booked in the second quarter of fiscal 2021, although that figure trailed the $2.2 million generated in the third quarter of fiscal 2020. Wovens also increased, reaching $1.7 million, up from $1.3 million during the second quarter of fiscal 2021, though that figure stayed under the $2.9 million recorded in the third quarter of fiscal 2020. Each of these markets illustrates the way COVID-19 has dragged down economic activity, and the second quarter of fiscal 2021 represented the bottom, since many industrial facilities closed for a time — particularly in automotive and transportation, and also in oil and gas, where crude prices have kept the squeeze in place. High-performance wear, one of the newer items we sell, contributed $740,000 in sales during the third quarter of fiscal 2021, an increase over the $500,000 seen in this year's second quarter and the $600,000 seen in the third quarter of fiscal 2020. Just as happened during the first half of the year, we think PPE buying stayed concentrated — or perhaps became reconcentrated in the third quarter — on pandemic-related needs, at the cost of some traditional industrial applications. That pattern seems to have softened across the third quarter, with additional gains heading into the fourth quarter. Turning to gross profits. Gross profit reached $21.7 million in this year's third quarter, rising $12.4 million, or 133%, over the $9.2 million recorded in the equivalent period a year earlier. As a share of sales, gross profit stood at 52.3% during the fiscal 2021 third quarter, setting a company record for any quarter and marking a gain exceeding 18 percentage points from 39.3% a year ago. Compared with this year's second quarter, when revenues totaled $35 million and gross profit came to $17.3 million, our third quarter gross margin rose 2.8 percentage points. The primary factors behind our gross margin gain versus the prior year period included fewer SKUs and extended operating hours, which produced better factory floor efficiencies, along with higher average selling prices, growth in direct container sales, and the addition and expansion of our specialized product lines carrying higher margins. Compared with the second quarter of this year, gross margin in the third quarter improved because revenues were even higher and we made more direct container sales, which produced added manufacturing efficiencies. We've begun to resume making a limited number of disposable and chemical SKUs—that is, product variations—that had been cut back or dropped in the first half. More items will come back in the fourth quarter, and some after that, though we expect the process of putting these products back into our manufacturing schedule to be deliberately paced and kept under control, so that as we emerge from COVID-19 we have a rationalized product offering that preserves most of the manufacturing efficiencies we've gained along with their impact on margins. In the end, we will provide fewer products than we did before COVID, and most of those discontinued are lower-selling lines and less profitable products. To sum it up, this simplification has produced shorter wait times for our customers, manufacturing that is both more productive and done in larger quantities, better gross margins, and an enhanced rate of inventory turnover. Just as during the opening six months of the year, our plants producing disposable and chemical goods have been operating close to their highest possible output on a 12-hour-a-day, 6-day-a-week timetable. Consequently, in Q3 we managed yet again to get products to customers at times when rivals—lots of them relying on outside contractors—were unable to do so. Because we could deliver goods promptly, we succeeded in bringing new buyers over to Lakeland items. In Q2, we observed a large number of these newly acquired customers putting in container-sized orders for substantial business that we think might be won entirely or partially moving forward. In Q3, we saw an even greater number of direct container orders. To handle the greater flow of orders along with expansion in newer, higher-margin goods and the relaunch of particular SKUs, we brought on close to 100 additional employees at our manufacturing sites. Throughout Q4, our plants have been cutting down on the hours they spend running near peak capacity. Because we sold so much more and our gross margins added so much, the operating leverage baked into our model produced substantial improvements in both profitability and cash flow.
Allen Dillard
executiveMeanwhile, we remain dedicated to making enhancements across the company, and that covers continuous cost control. Operating expenses rose because of increased sales and volume incentives, which led to bigger sales commission and compensation costs. Freight out declined thanks to larger container load shipments; in addition, travel and marketing costs were lower because of COVID-related restrictions. Bad debt reserves went down, though we did take on somewhat higher professional services fees tied to upgrading and extending our ERP system, which supports better margins and efficiency. For Q3, our operating expenses came to $9.2 million. In the same quarter last year, that figure was $7.5 million. The main factor behind the change was a $700,000 noncash expense — or recapture — related to stock-based compensation for grants made in 2018. Earlier, the company had reversed stock-based compensation expense on equity awards from 2018 and prior years, because at the time it seemed likely the company would fail to hit the performance thresholds required for vesting. Based on how FY '21 has gone so far, along with the corresponding benchmark results, that belief was revised. Consequently, during the third quarter the company recorded the stock option expense associated with those awards. In the third quarter, operating expenses equaled 22.2% of net sales. That compares with 21.7% during this year's second quarter, and 27.2% in the equivalent period twelve months earlier. Lakeland achieved an operating profit of $12.5 million for the third quarter — a record — against $9.7 million in the second quarter of fiscal 2021 and $1.8 million during last year's third quarter. Our operating margins stood at 30.1% in the third quarter, up from 27.8% in the second quarter and 6.7% one year prior. As for EBITDA margin, which excludes noncash expenses like the catch-up on stock-based compensation, it came in at 33.5% for our third quarter, climbing from 30.6% in our second quarter and 7% in the third quarter of fiscal 2020. During the quarter, free cash flow reached an all-time high of $12.6 million. That compares with $9.3 million in our second quarter and $1.1 million in the third quarter of fiscal 2020. Operating income came in higher, which meant our overall taxes were higher as well. Federal, state and foreign income taxes are all included in income tax expense; with an income tax rate of 25.9%, income tax expense for the third quarter of fiscal '21 totaled $3.2 million. That's up from $423,000 in the second quarter of fiscal 2020, when the tax rate was 4.3%, and from $700,000 in the third quarter of fiscal 2020, when the tax rate was 36.3%. We expect Lakeland's federal NOL to be fully used during FY '21. By October 31, 2020, the state NOL we project stands at about $20 million. For fiscal 2021's third quarter, net income reached $9.3 million — that's $1.16 per basic share and $1.14 per diluted share — versus $1.1 million, or $0.14 per basic and diluted share, in the prior-year period. Our stronger results reflected higher revenue and gross margin, disciplined cost management, more efficient operations, and improved factory utilization, although greater GAAP taxes and the noncash stock-based compensation charge partially offset those benefits. Basic shares outstanding totaled 8,019,980 as of October 31, 2020. During the third quarter, the company repurchased no shares under its $2.5 million stock buyback program, which was approved on July 19, 2016. So far, $1.7 million has gone toward share repurchases, leaving roughly $800,000 still available through that program. Lakeland's cash and cash equivalents stood at $40.2 million on October 31, 2020, compared with $34.9 million on July 31, 2020, and $14.6 million at the start of fiscal 2021. At October 31, 2020, inventories totaled $44.9 million, slightly above the level at the start of the fiscal year. Raw materials rose by more than $2 million, and we ended with $6 million of finished goods product in transit. Once converted, we expect our cash balance to rise further. When compared with how the fiscal year began, receivables had increased $9.2 million by the end of the third quarter of fiscal 2021, driven by higher sales, and days sales outstanding stayed steady, coming in around 53 days. On the payables side, accounts payable along with accrued expenses were up $5.2 million relative to the year's opening, and shareholders' equity was $28.5 million higher. Assets in total rose almost $33 million, moving from $99.4 million to $132.3 million, which also represents a gain of roughly $13 million compared with where things stood at the finish of the second quarter of fiscal 2021. As of October 31, 2020, the company owed nothing and had drawn nothing from the $12.5 million revolving credit facility it holds with Bank of America. As of October 31, 2020, we had $98.7 million in working capital. That compares with $86.6 million on July 31, 2020, and $66.9 million when the fiscal year began. The current ratio stood at 6.7:1 on October 31, an 8.9% gain over January 31, 2020. Third-quarter capital expenditures came to roughly $600,000, compared with $500,000 during the second quarter and $100,000 a year earlier. Looking at the full year, we expect CapEx of about $2 million, against $1 million in fiscal 2020 and $3.1 million in fiscal 2019. The bulk of this year's CapEx is directed at strategic capacity additions where needed, better manufacturing efficiency, and the continued phased worldwide deployment of our ERP system. When it comes to manufacturing infrastructure by itself, we intend to keep putting money into boosting the output capability for new product lines across Vietnam, India and Mexico. These expansions can be shifted among our main product lines — disposable, chemical and critical environment — which bolsters both the resilience and flexibility of our manufacturing, and works alongside the ways we already drive efficiency on the factory floor, helped by our ERP system and planning processes centered on data. Beyond the U.S., we'll keep rolling out our ERP system one country at a time across our bigger international operations over the coming 12 to 24 months. So in addition to the growth efforts for our top line, we anticipate pulling out still more profitability from the operations we run internationally, which represent about 50% of the whole business in the years to come. During fiscal 2021, so far this year, we produced $30 million in free cash flows, which is 10x what we had in the prior year, set against an enterprise value right now of roughly $120 million. That demonstrates outstanding results and value for the people who hold our shares. Our growing team across the world makes us extremely proud. Even though the third quarter was very strong for us, we are set up for further growth beyond COVID-19, while gaining considerably from the pandemic as we keep delivering for the worldwide health care community and also for our industrial customer base. That brings my comments to a close. I'll hand the call back to the operator so questions can begin.
Gerry Sweeney
analystGreat job on such a solid quarter. I'd like to begin with revenue, or actually, production. Clearly, we're entering a stretch where, based on what you've said, there's a bit of an uptick in the more conventional industrial segments, and perhaps worldwide economies are getting better. Yet at the same time, demand for PPE remains quite robust. Given that a number of your rivals rely on third-party manufacturing, could it be that certain industrial goods end up in short supply if the economy continues recovering while those competitors concentrate on PPE?
Charlie Roberson
executiveThat could happen, Gerry, and it's something that — what I believe is more probable to cause that is simply — I'd say the overall comeback of the industrial sector will be a net positive. In my view, a bigger factor behind such a shortage is probably global stockpiling of PPE. Only yesterday, an article in The Wall Street Journal noted that PPE reserves, in the U.S. at minimum, have reached just a 50% level of their target amounts; and that's mostly because of the ongoing COVID surge, so while stockpile supplies come in, they believe they've got sufficient, yet there's a leak at the bottom of the bucket, draining out just slightly more slowly than it fills.
Gerry Sweeney
analystUnderstood. So my read is that PPE is still holding up well, while at the same time demand keeps getting better over on the industrial side. You've probably got a longer period of overlap there, perhaps.
Charlie Roberson
executiveOur expectation is that the drop-off in COVID will arrive across the coming — yes — 3 quarters.
Gerry Sweeney
analystRight — six, nine, twelve months, though, yes.
Charlie Roberson
executiveCorrect. That's the case, and gains in the industrial sector will, to a certain extent, move in nearly the opposite direction.
Gerry Sweeney
analystUnderstood. Has any business been rejected by you? Or were you capable of serving everyone? Since previously, I'm aware there are certain folks who are merely opportunistic, showing up seeking equipment and possibly not remaining for extended stretches or possibly not making the shift to become longer-term clients. I'm simply wondering how that situation is unfolding with customers. Are certain ones being declined by you, or is capacity being filled in every case?
Charlie Roberson
executiveCertain business was declined by us during the early portion of Q1, the early portion of Q2. Those whom we declined are aware that our reason was deliberate; our initial strategy remains what we're following, meaning serving our industrial customers and satisfying COVID demand in areas where we have spare capacity. We've been lucky enough to keep growing that capacity through better efficiency. Consequently, it isn't the case that industrial business has been declined by us, yet certain stockpiling, RFPs and other chances, fairly substantial COVID opportunities, are things we've chosen not to chase owing to our dedication to our industrial accounts.
Gerry Sweeney
analystAll right, understood. Just a couple more fast ones regarding gross margin. Clearly, there are several moving pieces — fewer SKUs, extended hours. Permanent SKU count, longer hours gives more flexibility, a higher selling price probably also gives more flexibility — may not be the right term, but that's what I'm going with; and then mix. Looking ahead, with PPE perhaps dropping off and industrial rising, where might gross margins land? Or, if you'd rather not address that, among the items I just listed, which tend to be more lasting versus others that might shift?
Charlie Roberson
executiveI'll hand that over to Allen. He's the one who's run the numbers on our margins.
Allen Dillard
executiveAs Charlie noted during his portion, Gerry, a number of items are set to remain in place permanently moving ahead — the gains coming out of cutting SKUs, the efficiencies we get in planning, and essentially the fundamental operational pieces of how we manufacture overall, how we plan, how we distribute, and so on. Those, then, are the pieces we will oversee and steer ourselves as we move forward. It's the pricing side that will likely prove trickier. Still, as Charlie pointed out earlier, none of these product lines will see prices return to where they stood before the pandemic, simply because we expect demand for PPE to stay elevated on a sustained basis from here. That makes it, in all likelihood, the single largest swing factor when it comes to how margins are affected down the road.
Gerry Sweeney
analystUnderstood. That clears things up nicely. One more thing, though. I'm just trying to get the nuance here — direct container sales carry a bigger margin. Does that simply mean selling straight to customers and bypassing certain distributors? I'd like to grasp that better.
Charlie Roberson
executiveNot quite. What direct containers refers to is that the product never enters a distribution facility of ours. Loading happens at the plant where we make it, and from there it goes straight to the distributor or to the customer. That lets us eliminate plenty of the costs that sit in between.
Alex Fuhrman
analystFantastic. Nice work on a quarter that will go down in the record books. I'd like to dig deeper into your gross margin comments. During your prepared remarks, I believe you said certain SKUs that had been pulled back for a while are now being brought back. Could you expand on that a bit? In other words, do you believe this company at some point has to return to offering the complete lineup? Or does a leaner mix remain the plan moving forward? And when I combine that with pricing, I'm just attempting to grasp the pluses and minuses, I suppose, when you consider gross margin in something like the period after the pandemic, during the back half of the coming year.
Charlie Roberson
executiveYes. Regarding SKUs, the main thing we're up to is this: certain weak performers have been cut, and bringing them back is not something we ever plan to do. Honestly, a piece of our — the margin troubles we faced before the pandemic, when certain items were trailing us the way a heavy weight trails a ship. We've achieved a meaningful lift in margins; simply removing those items means it will hold up over time. When I say that — in any case, returning, say, to making spunbond polypropylene is not happening. I won't go into specifics on that, but guarding against anything is not really what it does. We have — because of how the COVID-19 process played out, our sales force, I believe, has gotten clear on who our customer is, who makes a good customer, and who places value on dependable delivery. Dependable delivery is what we lean toward safeguarding the most moving forward, since that's a product attribute end users appreciate and are willing to pay for. So if trimming SKUs makes our manufacturing leaner and more dependable, that's a key factor in how we choose our SKUs.
Alex Fuhrman
analystAll right, that's quite useful. Then may I inquire about your operations beyond the U.S.? Clearly, performance has been incredibly robust in what appears to be every region; and I realize Lakeland is — clearly, none of this happened by chance. You've poured massive resources into your sales team across emerging markets. Could you elaborate a bit on how competition plays out internationally in Europe and other foreign markets? My assumption is you hold a fairly substantial share in certain of those markets. When it comes to conversations about pricing or aspects of your expansion, does that begin to appear different in Asia, South America, or other emerging markets where you've been achieving rapid growth?
Charlie Roberson
executiveI wouldn't say — clearly, there are certain markets where our initial market penetration sits at a higher level. We lack — aside from possibly China, I'm not aware of any market — or Canada, does it fully — where penetration reaches the degree we enjoy in the U.S. Having said that, Europe certainly ranks lower, South America ranks lower, and Southeast Asia plus India rank lower. I believe a significant portion of our acceleration in those markets during this quarter reflects the spike in Europe that arrived — in fact, it came slightly before our own spike here in the U.S. Thus, we shifted and redirected production capacity toward Europe. And it reflects the reality that we began from reduced market penetration. The supply issues our customers have encountered in the U.S. exist worldwide; therefore, we've gained new customers in foreign markets where, honestly, there are simply more of them that we haven't yet engaged. So I'd say that's the main force behind that growth; we will come out of COVID-19 in foreign markets possessing stronger market penetration and stronger branding.
Analyst
analystSo I suppose the key thing on management's mind right now is: how do we get a better multiple assigned to this business? At 6x on an annualized quarterly run rate for earnings of more than $4 per share, with over 20% of market cash sitting on the balance sheet. The market simply appears not to be acknowledging just how extremely cheap Lakeland is right now — fair value, purely on where the market stands, would put us somewhere between the low and mid-$30s per share. Has there been any consideration — any thinking around expanding the stock buyback or issuing a special dividend?
Charlie Roberson
executiveThose conversations happen internally on a routine basis; and several options are on the table. Regarding our multiple, honestly speaking, I believe Lakeland is dragging its history along with it. For a variety of reasons, we've had several years of fairly stagnant results. I won't walk through the whole backstory. We were extremely well set up for COVID to arrive. And by that I mean not only set up for COVID, but the prior management team did an excellent job strengthening our balance sheet, so we stood ready for faster growth versus what we'd seen historically, whether or not COVID happened. COVID sped that up; and I'd say this is genuinely our third quarter of meaningful progress. I believe the market is partly waiting to determine whether we can keep this going once COVID is behind us. Once we demonstrate that, my expectation is the multiples you're referring to will show up. Beyond that, though, we aren't depending entirely on it. We're evaluating ways to use capital. I'd rather not go too deep into specifics there; but it's enough to say we're determined to put it to work very prudently.
Analyst
analystAll right. You folks are performing wonderfully. My hope is that the market will soon acknowledge how well management is doing.
Charlie Roberson
executiveThanks. We're grateful that you're taking part in this Lakeland Fiscal 2021 Third Quarter Financial Results Conference Call. Looking toward what's left of fiscal 2021, our position remains strong as the new benchmark of excellence for PPE makers across the globe. Thanks once more for being with us on today's call. Enjoy the rest of your day.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Lakeland Industries, Inc. transcript — plus 131,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Lakeland Industries, Inc. earnings transcripts and 131,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Lakeland Industries, Inc. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.